NDC 72934-2026

BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4%

Betamethasone Dipropionate 0.05% / Niacinamide 4%

BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4% is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Betamethasone Dipropionate; Niacinamide.

Product ID72934-2026_89569a9d-d53e-f72d-e053-2a95a90aa9b9
NDC72934-2026
Product TypeHuman Prescription Drug
Proprietary NameBETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4%
Generic NameBetamethasone Dipropionate 0.05% / Niacinamide 4%
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-05-20
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameBETAMETHASONE DIPROPIONATE; NIACINAMIDE
Active Ingredient Strength0 g/100g; g/100g
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-2026-2

30 g in 1 BOTTLE, PUMP (72934-2026-2)
Marketing Start Date2019-05-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-2026-2 [72934202602]

BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4% CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-20

Drug Details

Active Ingredients

IngredientStrength
BETAMETHASONE DIPROPIONATE.05 g/100g

OpenFDA Data

SPL SET ID:89569a9d-d53d-f72d-e053-2a95a90aa9b9
Manufacturer
UNII

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.